Sun Pharmaceutical Industries Ltd. closed 13.11% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

The Indian benchmark indices, the Sensex and Nifty50, opened higher on Thursday, buoyed by positive developments in the trade talks between India and the United States.

Stay updated with the Sun Pharma Stock Liveblog, your one-stop destination for real-time information and analysis of a leading stock. Explore the latest updates on Sun Pharma stock, including: Last ...

U.S. inspectors have found new breakdowns at a Sun Pharmaceuticals plant in India that produces medications for U.S. customers, ProPublica reported July 16. The FDA found the factory failed to ...

Megan Rose and Debbie Cenziper ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our ...

Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.

The FDA cracked down on two plants in India and one in Korea in separate recently released reports, citing issues ranging ...